Podcasts about bioengineering

Engineering a solution is one thing; making it work in a high-stakes clinical environment is another. This panel discussion features the minds who build the tech and the hands that use it. Leading bioengineers and frontline clinicians from NYU, NYU Abu Dhabi, the University of Michigan and the University of Maine deconstruct the challenges of medical device innovation. The topics include glaucoma and other chronic diseases such as metabolic, cardiovascular, and neurologic diseases. The discussion also touches on AI, robotics, and wearable technology to improve patient care. Panel Members Andreas Hielscher, Professor of of Biomedical Engineering, NYU Tandon School of Engineering Shy Shoham, Professor of Neuroscience and Ophthalmology, NYU School of Medicine and Tech4Health Giovanna Guidoboni, Professor of Electrical and Computer Engineering and Dean of Engineering and Computing, University of Maine Manjool Shah, Clinical Associate Professor of Ophthalmology and Visual Sciences and Associate Chair of Innovation, University of Michigan Sefy Paulose Joshi, Assistant Professor of Ophthalmology, NYU Langone Health Moderated by Yong-Ak (Rafael) Song, Professor of Mechanical Engineering and Bioengineering and 19 Washington Square North Faculty Fellow, NYUAD

Lyme disease is a real lemon. Despite mainstream medicine building a consensus about Lyme Disease and Alpha-Gal Syndrome, and despite conspiracies surrounding the rejection of that consensus in favor of laboratory experiments gone wrong (or as planned), these "diseases" work on assumption and statical fraud: Lyme is caused by the Deer Tick, which is associated in general with the disease, and a set of symptoms that are the body's reaction to nearly every potential hazard; AGS is caused by the Lone Star Tick, which is associated in general with an allergic reaction. In both cases, only a percentage of the people “infected” come down symptoms that could also be the result of poor dietary and lifestyle habits — see fatigue and bodily pain. The fact is, visit the doctor with the symptoms in 2021, you have COVID; visit the doctor today and you have Lyme or AGS. As for red meat allergies caused by ticks, the case by case reporting is hype and assumption/association. Are there weaponized ticks being dropped off in boxes in the woods? Probably not, considering “tick boxes” are very real preventative measures that can be purchased to attract the bugs for extermination. While we are busy arguing and calling each other names, a whole other reality awaits. *The is the FREE archive, which includes advertisements. If you want an ad-free experience, you can subscribe below underneath the show description.

Künstliche Intelligenz verändert gerade jede Branche – aber zwischen Co-Pilot-Lizenzen, Datenangst und Buzzword-Bingo bleibt oft die Frage: Wie kommt ein Unternehmen von ersten Experimenten zu echten, spürbaren Effizienzgewinnen im Alltag? Im Gespräch mit KI-Experte Michel Wandke geht es um souveräne KI-Plattformen, Prozessautomatisierung und die Frage, wie sich Mitarbeitende auf diese Reise mitnehmen lassen, statt sie zu verlieren.Gleichzeitig prallen große KI-Visionen auf knallharte Realität: begrenzte Budgets, volle IT-Backlogs, Sicherheitsbedenken und ein massiver Fachkräftemangel. Vor diesem Hintergrund zeigt das Gespräch, warum KI-Implementierung kein reines IT-Projekt ist, welche Rolle Management und Change-Management spielen und wie Unternehmen schrittweise – von ersten Use Cases bis zur eigenen souveränen KI – vorankommen können.Diese Fragen werden beantwortet:Was bedeutet KI-Souveränität und warum ist sie für Unternehmen so wichtig?Warum ist KI-Implementierung kein reines IT-Thema, sondern Chefsache?Wie kommen Unternehmen von „Wir haben ChatGPT getestet“ zu echten Business-Use-Cases?Wie können Meeting-Protokolle, Spesenabrechnungen & Co. mit KI entlastet werden?Warum ist KI vor allem harte Prozessarbeit und keine „Magie“?Wie lassen sich Mitarbeitende mitnehmen, die Angst vor Jobverlust haben?Welche Rolle spielen eigene KI-Plattformen, europäische Hoster und GPUs?Inwiefern wird KI zur Basistechnologie wie Strom oder Internet?Wo stehen wir heute auf der „Internet-Zeitleiste“ der KI-Entwicklung?Welche Chancen eröffnen Robotik und Bioengineering durch KI?Hier findet ihr Michel auf LinkedIn: https://www.linkedin.com/in/michel-wandke/

n this episode of Talking Industrial Automation, Lisa Richter sits down with Rob Goldsmith, Director of Industrial Systems at Matrix, to explore his unexpected journey from bioengineering student to automation leader overseeing one of North America's largest independent integration teams. Rob shares how Matrix "brings processes to life" through factory automation, network infrastructure, and industrial systems integration — from small retrofit projects to massive greenfield installations. He also explains automation in everyday terms using a simple "making soup" analogy, discusses the growing role of AI in manufacturing, and highlights why CSIA best practices and strong client relationships remain essential in a rapidly evolving industry. Tune in for insights on leadership, automation strategy, AI adoption, and the human side of industrial systems integration.

Fungi are “nature's biological recycling machines,” says guest Vayu Hill-Maini, a former chef turned bioengineer. That is, they take waste and turn it into good things. Hill-Maini now melds his scientific and culinary skills to create new foods, but also medicines, faux leather, pigments and other valuable products from mushrooms and molds. He uses CRISPR gene editing technology to “domesticate” these fungi – removing off-flavors and increasing nutritional content to make new-age cheeses, burgers, salami, and more. “We call it the DBTL cycle – design, build, taste, learn,” Hill-Maini tells host Russ Altman about his creative process on this episode of Stanford Engineering's The Future of Everything podcast. Have a question for Russ? Send it our way in writing or via voice memo, and it might be featured on an upcoming episode. Please introduce yourself, let us know where you're listening from, and share your question. You can send questions to thefutureofeverything@stanford.edu. Episode Reference Links: Stanford Profile: Vayu Hill-Maini Connect With Us: Episode Transcripts >>> The Future of Everything Website Connect with Russ >>> Threads / Bluesky / Mastodon Connect with School of Engineering >>> Twitter/X / Instagram / LinkedIn / Facebook Chapters: (00:00:00) Introduction Russ Altman introduces guest Vayu Hill-Maini, a professor of bioengineering at Stanford University. (00:03:33) From Chef to Bioengineer How Hill-Maini's culinary background led him to study food through science. (00:05:23) Building a Lab with a Kitchen Why his Stanford lab combines bioengineering research with culinary experimentation. (00:07:32) What Are Fungi? A primer on yeasts, molds, mushrooms, and their role in food and medicine. (00:10:22) Domesticating Fungi How humans have shaped fungi over thousands of years. (00:14:23) Mushrooms as a Food Source The nutrients, proteins, vitamins, and beneficial molecules found in fungi. (00:16:21) Fungi as Biological Recyclers Using fungi to turn food waste, agricultural waste, and other materials into useful products. (00:18:22) Making Waste-Based Foods Desirable Why taste, emotion, and culinary design matter for sustainable foods. (00:20:22) Engineering Delicious Fungi Using genetics and CRISPR to improve flavor, nutrition, and usability. (00:22:50) Gentle Genetic Tweaks Making small changes to reduce off-flavors or enhance useful traits. (00:23:46) Design, Build, Taste, Learn How the lab moves between kitchen and bench science to improve foods. (00:24:06) Chefs in the Lab How culinary collaborators help guide research and creativity. (00:28:58) Fungi-Based Materials The potential to create textiles, leather alternatives, and building materials. (00:31:03) Future In a Minute Rapid-fire Q&A: sustainability, students, and the promise of fungi. (00:33:25) Conclusion Connect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>>Twitter/X / Instagram / LinkedIn / Facebook Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Are you still using one-factor-at-a-time experiments for biosimilar development, losing months, missing interactions, and risking costly dead-ends?In this episode, David Brühlmann, host of the Smart Biotech Scientist Podcast, reveals how traditional "one factor at a time" screening in biosimilar development can take over 12 months, while the parallel group design massively accelerates discovery by grouping up to five factors per experiment and applying a multivariate analysis pipeline.Topics discussed:The limitations of traditional and large DoE designs and the advantages of parallel group design (00:08)Best practices for grouping compounds by biological mechanism with four essential rules (00:53)The importance of anchor compounds, separating strong modulators, and initial univariate screens for unknown compounds (01:43)Guidance on managing practical issues, including evaporation, liquid handling, osmolality, and replicating production processes (06:42)The use of multivariate analysis tools: Principal Component Analysis, Mahalanobis distance, and decision trees for candidate selection (10:14)Key results and outcomes from applying the parallel group method, including faster and more cost-effective quality modulator identification (12:46)Three improvements David would recommend today: prequalifying compounds, broader quality analytics, and hybrid modeling integration (13:49)The shift in mindset from “time problem” to “information problem” in process development (16:50)Extending the parallel group and multivariate approach to other areas like clone selection and scale-up decisions (17:52)Smart insight:Process development is fundamentally about generating actionable information, not just running more experiments. The parallel group, multivariate pipeline lets teams ask better questions, in parallel, with dramatically improved data yield. This mindset and methodology extend well beyond biosimilar media development into clone selection, feed design, and process characterization, wherever complexity would paralyze traditional approaches.If you want more detail, you can read the full article “Parallel experimental design and multivariate analysis provides efficient screening of cell culture media supplements to improve biosimilar product quality” published in Biotechnology and Bioengineering, which outlines the methods and findings behind this approach.If you're interested in hybrid modeling, here's what previous podcast guests have shared on the topic, offering perspectives from fundamentals to real-world applications.Episodes 05 - 06: Hybrid Modeling: The Key to Smarter Bioprocessing with Michael SokolovEpisodes 99 - 100: From Raw Data to Actionable Insights: Unlocking the Power of Process Models with Fabian FeidlEpisodes 137 - 138: Skip 90% of Bioreactor Runs: The In Silico Revolution in Bioprocess Development with Yossi QuintEpisodes 173 - 174: Mastering Hybrid Model Digital Twins: From Lab Scale to Commercial Bioprocessing with Krist GernaeyNext step: If this was useful, leave a review on Apple Podcasts or Spotify. It helps other scientists find this content, and it genuinely matters.Support the show

Are you stuck screening endless compounds in biosimilar development and still not hitting your quality targets? Efficient compound screening is one of the toughest bottlenecks in biopharma, with outdated methods slowing progress and risking critical quality attributes in monoclonal antibody development.David Brühlmann breaks down a practical, parallel framework for rapid compound screening that addresses interaction effects, masking, and data quality. Methods proven in challenging biosimilar development programs.Topics discussed:The historical bottleneck of one-at-a-time screening in drug discovery and the impact of high throughput methods (01:04)Problems with both one-factor-at-a-time and large design of experiments approaches when handling many variables (02:10)Description of the parallel group method: splitting 17 quality modulating compounds into five biologically relevant groups and running experiments in parallel (06:09)How grouping compounds by biological mechanism improves interpretability and experimental design (06:43)Strategies for minimizing dilution effects, toxicity risks, and masking in multi-factor screens (08:24)The importance of multivariate analysis: using principal component analysis (PCA), Mahalanobis distance, and decision trees to interpret and select optimal experimental conditions (10:31)Real-world outcomes: identifying optimal compound combinations in just two rounds of screening (15:20)Reflections on the evolving role of hybrid modeling and machine learning in biosimilar process optimization (15:54)In Part 2, the focus shifts to a hands-on approach, covering how to design compound groups based on biology, set concentration ranges without compromising data quality, and execute a 96-well screen with the rigor the method demands. It also highlights three key aspects that would be approached differently if the study were conducted today.Strategic insight:Effective compound screening shifts from one-at-a-time testing to biology-driven parallel grouping combined with multivariate analytics, enabling faster identification of optimal combinations while preserving data quality and capturing interaction effects.If you want more detail, you can read the full article “Parallel experimental design and multivariate analysis provides efficient screening of cell culture media supplements to improve biosimilar product quality” published in Biotechnology and Bioengineering, which outlines the methods and findings behind this approach.If you're interested in hybrid modeling, here's what previous podcast guests have shared on the topic, offering perspectives from fundamentals to real-world applications.Episodes 05 - 06: Hybrid Modeling: The Key to Smarter Bioprocessing with Michael SokolovEpisodes 99 - 100: From Raw Data to Actionable Insights: Unlocking the Power of Process Models with Fabian FeidlEpisodes 137 - 138: Skip 90% of Bioreactor Runs: The In Silico Revolution in Bioprocess Development with Yossi QuintEpisodes 173 - 174: Mastering Hybrid Model Digital Twins: From Lab Scale to Commercial Bioprocessing with Krist GernaeyNext step: If this was useful, leave a review on Apple Podcasts or Spotify. It helps other scientists find this content, and it genuinely matters.Support the show

In this episode of Status Check with Spivey, Mike has a conversation with Vincent Sheu, an attorney and AI startup founder with a JD and a Master's in Computer Science from Stanford (in addition to degrees in Statistics, Molecular and Cell Biology, and Bioengineering).Mike and Vincent discuss how he uses AI in his legal work today (19:20, 22:20), how he expects to be using AI in legal work in the future (37:23), how important his human contributions are vs. the contributions of AI (25:32), whether AI will be able to learn EQ (27:12), the sorts of AI tooling skills that employers are (and will be) looking for (29:19, 42:45) and how they screen for those skills (33:39), the benefits of using AI for legal work as well as the risks (24:04, 31:21, 44:23), how the next generation of lawyers will be advantaged and disadvantaged in the new landscape of legal practice (30:03), whether Vincent would hire a new lawyer who was brilliant and likable but has no familiarity with AI (32:52), Vincent's recruiting process out of law school (14:03) and what his hours looked like in biglaw vs. as an in-house general counsel (19:36), how Vincent went 23 for 25 during his law school admissions cycle as a “super splitter” (3:32), and more.Near the beginning of the episode, Mike and Vincent chat about a viral video from 2014 in which Vincent rapidly completed a Rubik's Cube at a college basketball game. While the original video is now private, you can find the referenced SportsCenter article here.Mike also mentions the recent case of a defendant attempting to use an AI avatar to make their opening argument in court. You can find that video here.You can listen and subscribe to Status Check with Spivey on ⁠⁠Apple Podcasts⁠⁠, ⁠⁠Spotify⁠⁠, and ⁠⁠YouTube⁠⁠. You can read a full transcript of this episode with timestamps here.

Show Notes 1 May 2026New Self-Healing Material Could Extend Life of Planes, Cars by Centuries Soo Kim Newsweek https://www.newsweek.com/self-healing-material-could-extend-life-planes-cars-centuries-11833122Chinese Scientists Bioengineering Plants with Firefly Genes to Glow Frank Landymore Futurism.com https://futurism.com/science-energy/bioengineering-plants-glow-light-cities https://www.youtube.com/watch?v=N1FAPvC123Q&t=1sScientists use AI to create ultra-strong, rust-proof steel for 3D-printed parts Christopher McFadden InterestingEngineering.com https://interestingengineering.com/innovation/ai-creates-rust-proof-steel https://www.youtube.com/watch?v=gMRDl64Ixq4&t=9sSmart contact lens monitors eye pressure and delivers glaucoma drugs Annalisa Merelli Statnews.com https://www.statnews.com/2026/04/08/glaucoma-smart-contact-lens-combines-monitoring-drug-delivery/ https://www.science.org/doi/10.1126/scitranslmed.ads9541Low-frequency wireless sensor tracks artery stiffening in real time BioTechToday.com https://biotech-today.com/low-frequency-wireless-sensor-tracks-artery-stiffening-in-real-time-with-less-interference/A Bizarre Worm Could Teach Humans to Regenerate Darren Orf Popular Mechanics https://www.popularmechanics.com/science/animals/a69047453/stem-cell-worm-regeneration/ https://www.youtube.com/watch?v=XNQK2-XdZD0Common Vitamin May Reduce Buildup of Alzheimer's Proteins David Nield ScienceAlert.com https://www.sciencealert.com/common-vitamin-may-reduce-buildup-of-alzheimers-proteins-study-findsScientists Found a Way to Grow Potatoes Under Solar Panels Now Solar

Michael Jewett is a pioneer of cell-free biotechnology. Instead of using living microbes as factories, he uses their internal molecular machinery to make valuable proteins, medicines, diagnostics, and other chemicals. Jewett recently used the technique for vaccine production in an approach that could produce up to 150,000 doses from one liter. He believes cell-free biotech could democratize the production of essential medicines, improve water safety, and help convert atmospheric carbon into useful products, among other promising possibilities. “It's just-add-water biotechnology,” Jewett tells host Russ Altman on this episode of Stanford Engineering's The Future of Everything podcast. Have a question for Russ? Send it our way in writing or via voice memo, and it might be featured on an upcoming episode. Please introduce yourself, let us know where you're listening from, and share your question. You can send questions to thefutureofeverything@stanford.edu. Episode Reference Links: Stanford Profile: Michael Christopher Jewett Connect With Us: Episode Transcripts >>> The Future of Everything Website Connect with Russ >>> Threads / Bluesky / Mastodon Connect with School of Engineering >>> Twitter/X / Instagram / LinkedIn / Facebook Chapters: (00:00:00) Introduction Russ Altman introduces Mike Jewett, a professor of bioengineering and chemical engineering at Stanford University. (00:03:23) What Is Cell-Free Biotechnology? Using the internal machinery of cells without the cells themselves. (00:04:20) Removing “Evolutionary Baggage” Why cells' natural priorities can conflict with engineering goals. (00:07:41) Advantages of Cell-Free Systems From large-scale production to decentralized, on-demand manufacturing. (00:11:40) Making Proteins Outside Cells How DNA instructions are used to produce functional proteins. (00:13:49) Biosensors for Water Safety Detecting contaminants like lead using engineered proteins. (00:17:05) Engineering Better Sensors Improving sensitivity and selectivity through protein design. (00:20:33) AI in Bioengineering How data and models accelerate discovery and design. (00:23:22) Sustainability & Carbon Capture Turning atmospheric carbon into useful chemicals. (00:26:18) Building New Biological Pathways Combining chemistry and biology to create novel production systems. (00:27:54) From Molecules to Materials How acetyl-CoA enables fuels, plastics, and other products. (00:30:51) Teaching Biotechnology Making biotech accessible through hands-on, “just-add-water” kits. (00:33:12) Future In a Minute Rapid-fire Q&A: innovation, collaboration, and the future of biotech. (00:35:32) Conclusion Connect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>>Twitter/X / Instagram / LinkedIn / Facebook Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Nobody builds a tower because they feel secure. We stack bricks and build our own kingdoms to protect ourselves from the unknown.In this message from the "Foundations" series, Pastor Adam Burton explores Genesis 10 and 11 to reveal the real motivation behind the Tower of Babel. Discover why God had to tear down what humanity built, how Pentecost reversed the curse of Babel, and why Jesus offers the security we desperately crave.

A listener recently called in asking how they might get a pair of functioning web shooters so they could operate as a local Spider-Man. While web shooters (sadly) don't exist, we can say that the ways real spiders use silk put Peter Parker's powers to shame. Spiders can use their sticky threads to sail through the air, capture prey larger than them, and even live underwater. And scientists trying to harness those powers.  Host Flora Lichtman chats with spider-silk aficionado Cheryl Hayashi about the wonders of silk, and Fiorenzo Omenetto shares how his engineering lab uses silk in the design of biomedical tools, like vaccines and sensors. Guests: Dr. Cheryl Hayashi is the senior vice president and provost of science at the American Museum of Natural History in New York City.  Dr. Fiorenzo Omenetto is a biomedical engineer and director of the Silklab at Tufts University in Massachusetts. Transcripts for each episode are available within 1-3 days at sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.

Recorded at the 2026 SCbio Annual Conference in Charleston, Heather and Matthew welcome Ken Webb, Professor of Bioengineering at Clemson University and Co‑Founder and President of NeuroHope Therapeutics. We have an exciting conversation about how Ken's research team is developing and commercializing novel drug‑delivery technologies aimed at treating central nervous system trauma, including spinal cord and traumatic brain injuries. Ken also reflects on his journey as an academic entrepreneur, the role of SCbio and other partners in supporting early‑stage life sciences startups, and what he sees ahead for innovation at the intersection of science and patient care. Tune in for insights on cutting‑edge research with a life-changing impact.

In this episode of The Psychedelic Podcast, Paul F. Austin speaks with a molecular geneticist exploring what it could look like to rethink how psychedelic medicines are sourced at a fundamental level. Find full show notes and links here: https://thethirdwave.co/podcast/episode-349/?ref=278  Jeffrey Gerst explains how his work in RNA biology and gene expression has led him to explore bioengineering as a way to produce psychedelic compounds without relying on wild harvesting or traditional chemical synthesis. The conversation looks at how cells organize and communicate, and how those same biological principles could be used to create more sustainable and scalable systems for medicine production. Paul and Jeff also reflect on the broader implications of this shift, from environmental stewardship to the long-term integrity of the psychedelic ecosystem. Professor Jeffrey Gerst is a molecular geneticist and Full Professor at the Weizmann Institute of Science, where he studies how cells regulate gene expression through RNA trafficking and localized protein synthesis. His research has advanced understanding of how mRNA moves within and between cells, revealing new forms of cellular communication and potential applications in therapeutic delivery. More recently, his work has expanded into the bioengineering of psychedelic compounds, with a focus on developing sustainable, scalable, and ethical methods of production. Highlights: Why sourcing is becoming a central challenge in psychedelics Bioengineering as a scalable alternative to wild harvesting How RNA biology informs new approaches to medicine production The limits of "natural" when demand increases Environmental risks of large-scale psychedelic use How yeast and cells can produce psychedelic compounds Balancing biotechnology with traditional practices What sustainable access could look like in the future The evolving relationship between science and psychedelics Episode Links: Prof. Jeffrey Gerst - Academic Profile (Weizmann Institute) Prof. Jeffrey Gerst - Metaformity (Project / Initiative) Episode Sponsors: Psychedelic Coacing Institute's Intensive for Psychedelic Professionals in Costa Rica - a transformative retreat for personal and professional growth. The Microdosing Practitioner Certification at Psychedelic Coaching Institute. The Practitioner Certification Program by Third Wave's Psychedelic Coaching Institute. Golden Rule - Get a lifetime discount of 10% with code THIRDWAVE at checkout Disclaimer: This content is for educational, informational, and entertainment purposes only. We do not promote or encourage the illegal use of any controlled substances. Nothing said here is medical or legal advice. Always consult a qualified medical or mental health professional before making decisions related to your health. The views expressed herein belong to the speaker alone, and do not reflect the views of any other person, company, or organization. Third Wave occasionally partners with or shares information about other people, companies, and/or providers. While we work hard to only share information about ethical and responsible third parties, we can't and don't control the behavior of, products and services offered by, or the statements made by people, companies, or providers other than Third Wave. Accordingly, we encourage you to research for yourself, and consult a medical, legal, or financial professional before making decisions in those areas. Third Wave isn't responsible for the statements, conduct, services, or products of third parties. If we share a coupon code, we may receive a commission from sales arising from customers who use our coupon code. No one is required to use our coupon codes.  

Podcast family we've all heard the rumors that oursmartphones are “LISTENING TO US”. Well, some of that is actually true, and trust me I'm not a conspiracy theorist. Our smartphones are capable of remarkable things. A new publication from the Green journal (released ahead ofprint on 03/05/2026 ) is proposing that it may now be able to detect fetal movement, fetal breathing, and even fetal hiccups when placed over the abdomen! Yep, it's not science fiction... it's science innovation. While this is not ready for prime time just yet, the science is absolutely astounding. In this quicky episode we will briefly summarize a fascinating new innovative study which proposes that our iPhones may be able to be a fetal movement detector.1.     Moise, Kenneth Jr MD; Gaither, Kelly PhD;Madden-Rusnak, Anna PhD; Lowry, Kathy RN, MSN; Hutson, Emily RN, MSN; Bruns, Danielle RDMS; Valero, Reinaldo MD, RDMS. Smartphone Detection of FetalMovements Using Artificial Intelligence. Obstetrics & Gynecology ():10.1097/AOG.0000000000006228, March 5, 2026. | DOI:10.1097/AOG.00000000000062282.     Lai J, Woodward R, Alexandrov Y, et al Performanceof a Wearable Acoustic System for Fetal Movement Discrimination. PloS One. 2017. 3.     Ashik AK, Gutierrez R, Ashraf F, et al. AMachine Learning Model for Assessing Fetal Health During Pregnancy. Frontiers in Bioengineering and Biotechnology. 2025. 4.     Antepartum Fetal Surveillance: ACOG PracticeBulletin, Number 229. Obstetrics and Gynecology. 2021.5.     Monitoring a Pregnancy at Home With a SmartphoneThis wearable device provides real-time ECG monitoring of a fetus: https://spectrum.ieee.org/pregnancy-heartbeat-monitor-smartphone

Your brain doesn't just run on chemistry. It runs on time.Every day your body broadcasts signals through sleep timing, light exposure, body temperature, hormones, and circadian rhythms—yet most people ignore these patterns while chasing pills, supplements, and productivity hacks.In this episode of the Crackin' Backs Podcast, we sit down with Benjamin Smarr to explore a new frontier of human biology: how time-series biology and wearable data may unlock powerful, non-drug ways to improve brain health, mood, and performance.Dr. Smarr's research looks at the body not as a snapshot—but as a movie, where continuous biological signals reveal patterns that traditional medicine often misses.In this episode, we explore:Why “normal” is a misleading concept in human biologyHow circadian rhythms and sleep timing shape mental performance and moodWhat wearable devices can reveal about your hidden biological patternsWhy body temperature rhythms may be linked to depression and mental healthThe overlooked role of light timing, temperature regulation, and daily rhythmsHow “social time” vs biological time affects cognition, sleep, and productivityWhere self-tracking and wearable data help—and where they can backfireWhether the future of medicine could include “time prescriptions” instead of drugsThis conversation reframes how we think about health, performance, and mental well-being—not as something fixed, but as something that shifts with how we live in time.If you're interested in sleep science, circadian biology, wearables, mental performance, precision health, and the future of non-drug brain optimization, this episode will challenge how you think about your own body.About Dr. Benjamin SmarrBenjamin Smarr is an Associate Professor of Bioengineering and Data Science at the University of California, San Diego (UCSD). He earned his PhD in Neurobiology from the University of Washington, and later served as an NIH fellow at UC Berkeley in Psychology.His research focuses on biological rhythms, neuroendocrinology, wearable health data, and HealthAI, developing technologies that improve precision medicine while reducing algorithmic bias for diverse populations.The Smarr Lab works at the intersection of women's health, aging, circadian biology, and data science, aiming to accelerate the future of personalized healthcare and population-level health insights.Dr. Smarr's work and insights have been featured in global media outlets including NPR, BBC, Forbes, and many others. He is also a strong advocate for science communication and community empowerment in discovery and health innovation.Learn more about his research and work HERE:  We are two sports chiropractors, seeking knowledge from some of the best resources in the world of health. From our perspective, health is more than just “Crackin Backs” but a deep dive into physical, mental, and nutritional well-being philosophies. Join us as we talk to some of the greatest minds and discover some of the most incredible gems you can use to maintain a higher level of health. Crackin Backs Podcast

In nature, enzymes are the catalysts that make much of biology work. They jumpstart chemical reactions that either wouldn't happen, or would happen super slowly. They break down food, build other molecules, extract energy, and more. What if we could harness evolution to engineer designer enzymes that do other specific jobs that benefit us?  Putting that idea into practice changed the game for chemistry, and earned Frances Arnold the Nobel Prize prize in 2018. She called it “directed evolution.” Today, thousands of labs use her methods to coax enzymes into doing things no one ever thought of. She joins Host Flora Lichtman to talk about where she sees this approach going in the future, and the personal evolution that brought her into science. Guest: Dr. Frances Arnold is the Linus Pauling Professor of Chemical Engineering, Bioengineering and Biochemistry at the California Institute of Technology in Pasadena, California.Transcripts for each episode are available within 1-3 days at sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.

What if robots could handle tedious retraction, precise bone milling, or even autonomous suturing, freeing surgeons to focus on complex decision-making and more patients?In this episode of the Succeed In Medicine Podcast, Dr. Bradley Block speaks with Dr. Michael Yip, as he explains that today's robots primarily serve as extensions of human surgeons via teleoperation (e.g., da Vinci for precision in hard-to-reach areas), enhancing dexterity, visualization, and accuracy rather than replacing them. He highlights existing autonomous applications in "hard tissue" procedures like the Mako or Stryker robots for precise bone milling in joint replacements, and non-contact examples like CyberKnife for focused radiation therapy.For soft tissue surgery, the more challenging domain due to tissue deformation and variability, autonomy is emerging in simpler, repetitive tasks such as retraction, suctioning, or basic suturing, with demonstrations dating back 15 years but real-world deployment lagging due to engineering, data, and economic hurdles. Dr. Yip discusses why demos in controlled settings don't easily translate to ORs, the shift to data-driven AI (with risks of out-of-distribution failures), and regulatory challenges like FDA expertise gaps and defining probabilistic safety. He predicts stepwise adoption: starting with assistant-level tasks (replacing med student/intern roles in retraction/suction), then progressing to free surgeons for higher-value work, especially in underserved rural areas via telesurgery. Full "skin-to-skin" autonomy (e.g., simple lipoma excision or appendectomy) remains years away, limited by hardware combining strength, dexterity, and precision in one system, though teams of specialized robots could accelerate progress. Ultimately, robotics will alleviate surgeon burnout from growing demand, not eliminate jobs soon.Three Actionable TakeawaysEmbrace Robotics Early in Training: Surgeons and trainees should gain hands-on experience with diverse robotic technologies now, treating them as essential tools that augment precision and dexterity rather than threats to obsolescence.Focus on Repetitive Tasks for Autonomy Gains: Prioritize robotic assistance in tedious, physically demanding steps like retraction, suctioning, or basic closure to free up time, reduce fatigue, and improve efficiency in high-volume or resource-limited settings.Stay Informed on Regulatory and Economic Shifts: Monitor evolving FDA guidelines for AI/surgical autonomy, economic incentives (e.g., cost savings in joint replacements or anastomosis), and liability frameworks to prepare for integration that enhances patient access and outcomes.About the Show:Succeed In Medicine covers patient interactions, burnout, career growth, personal finance, and more. If you're tired of dull medical lectures, tune in for real-world lessons we should have learned in med school!About the Guest:Dr. Michael Yip is an Associate Professor of Electrical and Computer Engineering at UC San Diego and Director of the Advanced Robotics and Controls Laboratory (ARCLab). His research focuses on surgical robots, biomimetic design, robot learning, autonomous robotic surgery, and deformable tissue manipulation. He has received the NSF CAREER Award, NIH Trailblazer Award, IEEE RAS Distinguished Lecturer recognition, and was named Faculty Innovator of the Year at UCSD in 2024 and elected to the National Academy of Inventors. Previously a Disney researcher at Amazon Robotics, he holds a BSc in Mechatronics Engineering from the University of Waterloo, MS in Electrical Engineering from the University of British Columbia, and PhD in Bioengineering from Stanford University.Website: yip.eng.ucsd.edu and ucsdarclab.comAbout the Host:Dr. Bradley Block – Dr. Bradley Block is a board-certified otolaryngologist at ENT and Allergy Associates in Garden City, NY. He specializes in adult and pediatric ENT, with interests in sinusitis and obstructive sleep apnea. Dr. Block also hosts Succeed In Medicine podcast, focusing on personal and professional development for physiciansWant to be a guest?Email Brad at brad@physiciansguidetodoctoring.com  or visit www.physiciansguidetodoctoring.com to learn more!Socials:@physiciansguidetodoctoring on Facebook@physicianguidetodoctoring on YouTube@physiciansguide on Instagram and Twitter   This medical podcast is your physician mentor to fill the gaps in your medical education. We cover physician soft skills, charting, interpersonal skills, doctor finance, doctor mental health, medical decisions, physician parenting, physician executive skills, navigating your doctor career, and medical professional development. This is critical CME for physicians, but without the credits (yet). A proud founding member of the Doctor Podcast Network!Visit www.physiciansguidetodoctoring.com to connect, dive deeper, and keep the conversation going. Let's grow! Disclaimer:This podcast is for informational purposes only and is not a substitute for professional medical, financial, or legal advice. Always consult a qualified professional for personalized guidance. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Oscar Castaño Linares is a professor at the University of Barcelona and a researcher at the Institute for Bioengineering of Catalonia in the department of Biomaterials for Regenerative Therapies. Through his research, Oscar has been working with 3D printers to print scaffolds that enhance the growth of blood vessels. These are like homes for cells to inhabit, so they have to be porous, biodegradable, and non-toxic. Like a craftsman learning a trade, Oscar's research has taken him all over the world to learn new techniques, but with the goal of transferring that knowledge to his students and to other scientists. Oscar joins us to share how he can print these biomaterials while describing his path in science that led him to this research. Show notes at: https://laboutloud.com/2026/02/episode-285-biomaterials/

Leon Bibi is a researcher and author who explores the provocative theory of alien intervention in the human genome and evolutionary development. Bibi examines anomalies in human DNA, sudden evolutionary leaps, ancient myths, and modern scientific findings to suggest that non-human intelligence may have played a role in shaping humanity's biological and cognitive evolution. His work bridges genetics, ancient astronaut theory, and alternative anthropology, encouraging discussion about humanity's origins, the possibility of guided evolution, and the broader implications of extraterrestrial involvement in human history.Become a supporter of this podcast: https://www.spreaker.com/podcast/the-x-zone-radio-tv-show--1078348/support.Please note that all XZBN radio and/or television shows are Copyright © REL-MAR McConnell Meda Company, Niagara, Ontario, Canada – www.rel-mar.com. For more Episodes of this show and all shows produced, broadcasted and syndicated from REL-MAR McConell Media Company and The 'X' Zone Broadcast Network and the 'X' Zone TV Channell, visit www.xzbn.net. For programming, distribution, and syndication inquiries, email programming@xzbn.net.We are proud to announce the we have launched TWATNews.com, launched in August 2025.TWATNews.com is an independent online news platform dedicated to uncovering the truth about Donald Trump and his ongoing influence in politics, business, and society. Unlike mainstream outlets that often sanitize, soften, or ignore stories that challenge Trump and his allies, TWATNews digs deeper to deliver hard-hitting articles, investigative features, and sharp commentary that mainstream media won't touch.These are stories and articles that you will not read anywhere else.Our mission is simple: to expose corruption, lies, and authoritarian tendencies while giving voice to the perspectives and evidence that are often marginalized or buried by corporate-controlled media

THE RIPPLE EFFECT PODCAST:Website: http://TheRippleEffectPodcast.comSupport: https://rickyvarandas.com/support/IPAK-EDU (Empower Yourself Through Knowledge)Website: https://IPAK-EDU.org/ (use RIPPLE for 10% off)VN Alexander, PhD (aka Tori)Website: https://vnalexander.com/IG: https://www.instagram.com/rednaxelairot/AI & Transhumanism Essay: posthumousstyle.substack.comBio: Philosopher of science known for her work on Vladimir Nabokov's theory of insect mimicry evolution. She is a member of the Third Way of Evolution research group and currently works in the field of Biosemiotics.  She earned her Ph.D. in 2002 in English at the Graduate Center, City University New York and did her dissertation research in teleology, evolutionary theory, and self-organization at the Santa Fe Institute. She is a Rockefeller Foundation Residency alum, a former NY Council for the Humanities scholar, and a 2020 Fulbright scholar in Russia. Books include The Biologist's Mistress: Rethinking Self-Organization in Art, Literature and Nature and several literary fiction and political science novels.Xavier A. Figueroa, Ph.D (aka Dr. X)X: https://x.com/DrXFig0708Bio: The principal scientist for EMulate Therapeutics overseeing pre-clinical research and the application of EMulate Therapeutics technology in multiple disease areas. He has more than 20 years of experience in basic and neurological clinical research, including Alzheimer's research, neuron biology, cancer research, bioengineering and biophysics. Dr. Figeuroa received his doctoral degree in Neurobiology & Behavior from the University of Washington. His doctoral training was followed by two post-doctoral fellowships within the University of Washington's Department of Bioengineering. He is currently an affiliate assistant professor in the School of Medicine at the University of Washington. Specialties include, Molecular Biology, Toxicology, Apoptosis Signaling and Regulation, Neuroscience and Neurodegenerative Expertise.Dr. James Lyons-Weiler (aka Dr. Jack)Website: https://jameslyonsweiler.com/Substack: https://popularrationalism.substack.com/Earned his PhD in Ecology, Evolution, and Conservation Biology. He has held research positions at esteemed institutions, including the University of Nevada, Reno, and the University of Pittsburgh (Dept Pathology & Dept. of Biomedical Informatics). Dr. Lyons-Weiler has an extensive portfolio of peer-reviewed articles covering various scientific disciplines such as genetics, evolution, and public health. Notably, he has conducted research on the safety of aluminum adjuvants in vaccines, focusing on their dosing and potential health implications, especially in pediatric populations. His work on “pathogenic priming” and its potential relevance to COVID-19 has also been significant. Lyons-Weiler founded the Institute for Pure and Applied Knowledge (IPAK), a research organization. He also founded IPAK-EDU, an educational platform that has educated over 1,400 students in advanced courses across a wide variety of subjects. You can find more information about these courses on their official website.

On this week's Tech Nation, Moira speaks with Dr. Shana Kelley, President of Bioengineering and Head of Biohub Chicago,  about AI-Powered Biology - what is it? And what could it mean for the future of research? Then, Dr. Harry Selker and Dr. Atul Deshpande of Immediate Therapeutics tell us how they've come up with a speedy intervention for heart attacks. And, what exactly differentiates the NIH, the FDA, and the CDC? We take a closer look at that, and what they have in common.

All cutting-edge medical treatments come with side effects that can limit their benefit. In this talk, Prof. Ramadi explores how we can make medicine better—by moving beyond today's one-size-fits-all approaches toward smarter, personalized interventions. With breakthroughs in nanotechnology, artificial intelligence, and advanced therapeutics, we are rethinking how medicine can not only treat disease but extend healthy years of life worldwide. Speaker Khalil Ramadi, Assistant Professor of Bioengineering, NYU; Director of the Laboratory for Advanced Neuroengineering and Translational Medicine, NYUAD

What does it take to return to the top of the ultra running world after major life changes and a "career-ending" surgery? Kaytlyn Gerbin knows. In this episode, Kaytlyn shares her journey from a scientist with a love for the outdoors to a world-class trail and ultra runner. Growing up active but without formal running experience, she discovered her talent in her mid-twenties and quickly fell in love with the 100-mile distance. Since then, she's set course records, tackled some of the most technical alpine trails in the Pacific Northwest, and stood on podiums at legendary races like UTMB, Western States 100, and Transgrancanaria. But Kaytlyn's story isn't just about running. It's about resilience, reinvention, and balance. After the birth of her daughter Era in 2024 and undergoing surgery to correct hip dysplasia—a procedure many thought would end her running career—Kaytlyn came back stronger than ever, winning the Cascade Crest 100 and taking on the epic 330km Tor des Geants race in Italy. In this episode, you'll hear about: How she discovered her running talent and found her passion for ultra distances Overcoming setbacks, starting over, and learning to meet herself where she is The mental strategies that help her tackle 100-mile races and multi-day alpine challenges Balancing motherhood with elite-level running Her plans and goals for 2026, including Hardrock 100 and UTMB Whether you're an aspiring ultra runner, a parent chasing big goals, or someone who loves stories of grit, perseverance, and adventure, Kaytlyn's story will inspire you to push your limits—on the trails and in life. Tune in to hear how Kaytlyn combines mountains, motherhood, and science-backed training to redefine what's possible, one long run at a time. ***  New episodes of the Tough Girl Podcast drop every Tuesday at 7 AM (UK time)! Make sure to subscribe so you never miss the inspiring journeys and incredible stories of tough women pushing boundaries.  Do you want to support the Tough Girl Mission to increase the amount of female role models in the media in the world of adventure and physical challenges? Support via Patreon! Join me in making a difference by signing up here: www.patreon.com/toughgirlpodcast.  Your support makes a difference.  Thank you x *** Show notes Who is Kaytln Ultra runner and trail runner for the North Face Living in the foothills outside of Seattle, US Having a degree in Bioengineering and previously working as a scientist  Having her first daughter, 14 months ago Reflecting back on her childhood and early years Growing up in rural US Being the oldest of four and being very active as a kid How her running journey progressed Playing soccer in high school Being good at running on the field, but not enjoying the running for training Making friends with other students at college who ran Discovering her running talent in her mid-twenties Entering her first small, local race and finishing 2nd female Having fun and feeling strong while running  Finding her distance  Loving the 100 mile distance  Figuring out training for races The longer she ran, the stronger she felt  Feeling overwhelmed by the running distances  Having to start over with her running Remembering how hard it is to start running again after set backs Having a hard time with running  Never having a running coach and getting to make all the rules Tracking her training  Meeting yourself where your at ie being ok with walking  Bringing in science to her running? Lessons on failure and how it applies to running Staying humble with her running Why the hardest part of the race, is just before it starts The anxiety before a race, struggling to sleep and eat before Staying relaxed while running and settling into the run after 50k Running through the night Taking some time before doing the hard thing, and thinking about the mental challenges which may come up and how to handle it Running a 220 mile race over 4 days Dealing with the guilt of being away from her baby while running  Anticipate what some of the mental challenges might be during a race and how best to approach it Taking a step back from the running during pregnancy  Not feeling the pressure to go back to running Her 'A' race in 2025 Tor des Geants 330km race in Italy   Winning the Cascade Crest 100 mile race  Seeing the 2nd placed woman - starting to race Wanting to run hand and push herself Plans for 2026 Applying for Hardrock 100 mile race Wanting to go back and race at UTMB  Having a pregnancy deferral for UTMB   How to connect with Kaytlyn Advice for women wanting to take on a 100 mile race   Social Media Instagram @kaytlyn_g  

Nabeel Kaukab is the Founder and CEO of Jaan Health, a software company transforming chronic disease management with AI-powered virtual care. He brings over 25 years of experience bridging healthcare and emerging technology. Before starting Jaan Health, he spent a decade as a Healthcare Investment Banker at UBS & Barclays Capital, where he advised on and executed IPOs, acquisitions and other financings worth more than $50 billion. Prior to that, Nabeel was an early-stage hire and software developer at Viant Corporation, where he helped build some of the earliest Internet applications and open several offices in the US and Europe, leading to the company's successful 1999 IPO. He has a BA in Neuroscience and Behavior from Columbia University and attended graduate school for Biotechnology & Bioengineering at the University of Pennsylvania. Hosted on Acast. See acast.com/privacy for more information.

The world of prehospital medicine is constantly evolving, driven by new research, technological advancements, and a shared commitment to improving patient care and provider well-being. As EMS professionals, staying informed about these developments goes beyond a professional obligation; it is an opportunity to improve our practice, champion our profession, and ultimately make a greater impact on saving lives. In this article, we will explore some of the latest research findings that are reshaping our field, from workplace culture to cutting-edge technology.   The Culture of Care: Supporting EMS Providers Our work is demanding, both physically and emotionally, and the culture within our agencies plays a critical role in our well-being. A recent systematic review in the International Journal of Environmental Research and Public Health revealed that many EMS providers avoid using organizational mental health services due to stigma and a perception that these programs lack genuine care. The study emphasizes the need for person-centered support and a cultural shift that normalizes seeking help as a sign of strength (Johnston et al., 2025). This cultural component also impacts retention. Another study in the same journal found that agencies with collaborative, team-oriented "clan" cultures had significantly lower turnover rates compared to those with rigid or chaotic structures. For leaders in EMS, fostering a supportive environment is not just about morale. It is a strategic imperative for retaining skilled clinicians (Kamholz et al., 2025).   Professional Recognition: Breaking Barriers Across the globe, paramedics are striving for recognition as integrated healthcare professionals. A qualitative study in BMC Health Services Research identified common barriers, including outdated legislation, inconsistent regulation, and insufficient funding. While the pandemic temporarily highlighted our capabilities, the momentum has waned. The study calls for targeted policy reforms and investments in education and leadership to solidify our role in the broader healthcare system (Feerick et al., 2025). Physical Demands and Injury Prevention The physical toll of our work is undeniable. A scoping review in Applied Ergonomics confirmed that musculoskeletal injuries, particularly to the back, are rampant in EMS. Tasks like handling stretchers and patient extractions are among the most strenuous. The review also highlighted fitness disparities, with male paramedics generally showing more strength but less flexibility than their female counterparts. These findings underscore the need for targeted injury prevention programs and realistic physical standards to keep us safe throughout our careers (Marsh et al., 2025).   Advancements in Cardiac Arrest Care When it comes to cardiac arrest, every second counts. A study in Resuscitation reinforced the value of bystander CPR, showing that dispatcher-assisted CPR significantly improves outcomes for untrained bystanders. For those with prior CPR training, acting independently yielded even better results. This highlights the importance of public CPR education alongside dispatcher support (Tagami et al., 2025). On the scene, our interventions matter immensely. Research in The Journal of Emergency Medicine found that for traumatic cardiac arrest patients, aggressive interventions like prehospital thoracostomy can be lifesaving (McWilliam et al., 2025). Meanwhile, a study in Critical Care Medicine revealed that extracorporeal CPR (ECPR) significantly improves outcomes for patients with refractory ventricular fibrillation, emphasizing the need for early transport to specialized centers.   The Role of Technology in EMS Technology is poised to revolutionize EMS, from dispatch to diagnosis. A study in The American Journal of Emergency Medicine demonstrated that large language models (LLMs) like ChatGPT could prioritize ambulance requests with remarkable accuracy, aligning with expert paramedic decisions over 76 percent of the time. This proof of concept suggests that AI could one day enhance resource allocation in dispatch centers (Shekhar et al., 2025). On the diagnostic front, machine learning is opening new possibilities. For example, a study in Bioengineering showed that analyzing photoplethysmography waveforms could estimate blood loss in trauma patients, offering a non-invasive way to guide resuscitation (Gonzalez et al., 2025). Similarly, research in Medical Engineering & Physics explored using multidimensional data to differentiate ischemic from hemorrhagic strokes in the field, potentially enabling more targeted prehospital care (Alshehri et al., 2025).   Addressing Disparities in Care Equity in EMS is a cornerstone of our profession, yet recent studies highlight troubling disparities. Research in JAMA Network Open found that ambulance offload times were significantly longer in communities with higher proportions of Black residents (Zhou et al., 2025). Another study in JAMA Surgery revealed that Black and Asian trauma patients were less likely to receive helicopter transport compared to White patients. These findings are a call to action for all of us to examine our systems and biases to ensure equitable care for every patient (Mpody et al., 2025).   Looking Ahead The research discussed here represents just a fraction of the advancements shaping EMS today. From improving workplace culture and injury prevention to leveraging AI and addressing systemic inequities, these findings have real-world implications for our protocols, training, and advocacy efforts. As EMS professionals, we have a responsibility to stay informed and apply these insights to our practice. For a deeper dive into these topics and more, I invite you to listen to the podcast, EMS Research with Professor Bram latest episode, https://youtu.be/rt_1AFzSLIk "Research Highlights and Innovations Shaping Our Field.”   References Alshehri, A., Panerai, R. B., Lam, M. Y., Llwyd, O., Robinson, T. G., & Minhas, J. S. (2025). Can we identify stroke sub-type without imaging? A multidimensional analysis. Medical Engineering & Physics. https://doi.org/10.1016/j.medengphy.2025.104364 Feerick, F., Coughlan, E., Knox, S., Murphy, A., Grady, I. O., & Deasy, C. (2025). Barriers to paramedic professionalisation: A qualitative enquiry across the UK, Canada, Australia, USA and the Republic of Ireland. BMC Health Services Research, 25(1), 993. https://doi.org/10.1186/s12913-025-10993-7 Gonzalez, J. M., Holland, L., Hernandez Torres, S. I., Arrington, J. G., Rodgers, T. M., & Snider, E. J. (2025). Enhancing trauma care: Machine learning-based photoplethysmography analysis for estimating blood volume during hemorrhage and resuscitation. Bioengineering, 12(8), 833. https://doi.org/10.3390/bioengineering12080833 Johnston, S., Waite, P., Laing, J., Rashid, L., Wilkins, A., Hooper, C., Hindhaugh, E., & Wild, J. (2025). Why do emergency medical service employees (not) seek organizational help for mental health support?: A systematic review. International Journal of Environmental Research and Public Health, 22(4), 629. https://doi.org/10.3390/ijerph22040629 Kamholz, J. C., Gage, C. B., van den Bergh, S. L., Logan, L. T., Powell, J. R., & Panchal, A. R. (2025). Association between organizational culture and emergency medical service clinician turnover. International Journal of Environmental Research and Public Health, 22(5), 756. https://doi.org/10.3390/ijerph22050756 Marsh, E., Orr, R., Canetti, E. F., & Schram, B. (2025). Profiling paramedic job tasks, injuries, and physical fitness: A scoping review. Applied Ergonomics, 125, 104459. https://doi.org/10.1016/j.apergo.2025.104459 McWilliam, S. E., Bach, J. P., Wilson, K. M., Bradford, J. M., Kempema, J., DuBose, J. J., ... & Brown, C. V. (2025). Should anything else be done besides prehospital CPR? The role of CPR and prehospital interventions after traumatic cardiac arrest. The Journal of Emergency Medicine. https://doi.org/10.1016/j.jemermed.2025.02.010 Mpody, C., Rudolph, M. I., Bastien, A., Karaye, I. M., Straker, T., Borngaesser, F., ... & Nafiu, O. O. (2025). Racial and ethnic disparities in use of helicopter transport after severe trauma in the US. JAMA Surgery, 160(3), 313–321. https://doi.org/10.1001/jamasurg.2024.5678 Shekhar, A. C., Kimbrell, J., Saharan, A., Stebel, J., Ashley, E., & Abbott, E. E. (2025). Use of a large language model (LLM) for ambulance dispatch and triage. The American Journal of Emergency Medicine, 89, 27–29. https://doi.org/10.1016/j.ajem.2025.05.004 Tagami, T., Takahashi, H., Suzuki, K., Kohri, M., Tabata, R., Hagiwara, S., ... & Ogawa, S. (2025). The impact of dispatcher-assisted CPR and prior bystander CPR training on neurologic outcomes in out-of-hospital cardiac arrest: A multicenter study. Resuscitation, 110617. https://doi.org/10.1016/j.resuscitation.2025.110617 Zhou, T., Wang, Y., Zhang, B., & Li, J. (2025). Racial and socioeconomic disparities in California ambulance patient offload times. JAMA Network Open, 8(5), e2510325. https://doi.org/10.1001/jamanetworkopen.2025.10325  

Adam Michaels, CEO of Mama's Creations, joins Food Institute Vice President of Content and Client Relationships Chris Campbell to discuss how the deli category is evolving and why this rapidly growing segment is primed for innovation. A veteran of global CPG and strategy roles at Booz Allen Hamilton and Mondelez, Michaels shares how Mama's Creations has transformed from a regional meatball company into a national, full-service deli solutions provider serving retailers across all 50 states. During the conversation, Michaels explains how the company is addressing some of grocery retail's most pressing challenges, including labor shortages, changing consumer meal preferences, and the need for greater efficiency in the deli case. He outlines how Mama's Creations supports retailers with a wide range of prepared foods, proteins, sides, and globally inspired flavors — all designed to simplify in-store execution while maintaining quality and consistency for shoppers. Michaels also details how strategic acquisitions, vertically integrated manufacturing, and a disciplined focus on metrics are fueling the company's growth. As the only publicly traded deli company in the U.S., Mama's Creations is leveraging scale, operational rigor, and data-driven decision-making to compete in the $40+ billion deli prepared foods category, while continuing to expand its national footprint and product capabilities. More About Adam Michaels: Adam Michaels is an experienced food industry executive and former management consultant with broad experience transforming consumer-focused companies. Previously, Adam served with Mondelez International, a multinational food and beverage company with operations in over 150 countries. Over the past nine years, he has held numerous roles with increasing responsibility at Mondelez across Supply Chain, Commercial Sales & Marketing and Strategy. Adam led Mondelez's North American Insights & Analytics organization and was most recently responsible for M&A and Commercial for North American Ventures – a business unit comprised of high growth brands including Perfect Snacks, a refrigerated snacks brand, Hu, an ultrasimple multi-category lifestyle brand, and Tate's Bake Shop, a premium cookie brand, among others. Before joining Mondelez, Adam was a Principal at Booz & Company, a management consulting firm, for seven years where he specialized in the Food & Beverage sector. He started his career at Capital One Financial and holds an MBA in Marketing & Management from Columbia Business School, as well as a BSE in Bioengineering from the University of Pennsylvania. Adam has lived and worked in the US, England and France. He lives with his wife and their two boys in New Jersey. More About Mama's Creations: Mama's Creations is your ultimate destination for fresh, easy-to-prepare dishes that capture the essence of grandma-quality food. Built off the authentic Italian heritage of Mama Mancini's, our name pays tribute to the treasured kitchens of grandmothers worldwide, where each meal is crafted with passion and care. At Mama's Creations, we understand the value of convenience without compromising on quality. We bring together a diverse range of culinary traditions and flavors, offering you an unforgettable taste experience. With fresh ingredients and our simple preparation methods, we ensure that every dish is a celebration of authentic homemade goodness. Learn more: https://mamascreations.com/

Dr Annelise E. Barron Associate Professor of Bioengineering Dr Annelise E. Barron is the W.M. Keck Associate Professor of Bioengineering at Stanford University Education: Postdoc, UCSF/Chiron Corporation, Biomimetic & Bioorganic Chemistry (1997) Postdoc, Soane BioSciences/ACLARA Biosciences Inc., Molecular Biotechnology (1996) Ph.D., Univ. of California, Berkeley, Chemical Engineering (1995) B.S., Univ. of Washington, Seattle, Chemical Engineering (1990) Stanford Web page: https://med.stanford.edu/profiles/annelise-barron?tab=bio Laboratory web page: https://barronlab.stanford.edu/   Complete List of Published Works in MyBibliography: https://www.ncbi.nlm.nih.gov/myncbi/annelise.barron.1/bibliography/public/   Email: aebarron@stanford.edu   If you liked this and want to learn more go to my new website www.DrAnthonyChaffee.com

The National Institutes of Health have historically funded scientists to find cures for diseases and protect public health. NIH funding has led to the discovery of immune therapies for cancer, antiviral treatments and prevention of HIV, and ground-breaking research into memory loss and Alzheimer's disease. After a year of funding cuts and freezes that have rocked the medical research field to its core, we catch up with leading researchers at the University of California to talk about the impact this has had on their work and our ability to fight humanity's most puzzling illnesses. Guests: Monica Gandhi, infectious disease expert and professor of medicine at University of California San Francisco - she is the director of the UCSF Gladstone Center for AIDS Research and the medical director of the San Francisco General Hospital HIV Clinic, Ward 86 Pamela Munster, professor of medicine at the University of California San Francisco; co-director, Center for BRCA Research, Medical Oncology; distinguished professor in Hereditary Cancer Research Megan Molteni, science writer, STAT News Joel Spencer, associate professor of Bioengineering, University of California Merced - his lab uses funding from NIH to study the thymus, with implications for cancer treatment and healthy aging Learn more about your ad choices. Visit megaphone.fm/adchoices

The Harvard Plan, a collaboration between On the Media and The Boston Globe, is about the fight for the soul of America's oldest and most prestigious university. In the new season, they explore what has unfolded at Harvard since Donald Trump's inauguration in 2025. Three main characters, inside Harvard, tell the story from their perspective: politics professor Ryan Enos, genetics professor and cancer researcher Kamila Naxerova and campus conservative Kit Parker, lieutenant colonel in the United States Army Reserve and Professor of Bioengineering and Applied Physics. Find more On the Media every week, here: https://podcasts.apple.com/us/podcast/on-the-media/id73330715.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

Title:  EP 131:  “Three Hearts, One Journey:  The Massie Family's Journey with Alport Syndrome”   

Liz is joined on the podcast by Becky Lai, Chief Strategist and VP of Marketing, to talk about the true North Star of commercialization: standard of care. Their discussion reframes success as more than building a product—it's about building a market where the product is trusted, adopted, and indispensable. Together, they explore how purposeful training, meaningful KOL engagement, and a clear strategic vision accelerate adoption and move technologies from launch to lasting impact.In 2025, we're embarking on a MedDevice Training Journey: From clinical trials to standard of care. Join us all year long as we explore training at each stage of the product life cycle.Need help developing your clinical trial training strategies? Contact us at training@cumbyconsulting.com.Related Resources:Rebecca Lai is the Chief Strategist and Marketing Executive at Rebecca Lai Consulting. She is a strategy and commercial executive with over 20 years of experience in medical and health technology companies, ranging from venture-backed startups to Fortune 200 corporations. As a dynamic strategic operator specializing in go-to-market, commercialization, and innovative business strategies, she has consistently driven double-digit growth and scaled new businesses with global impact. With a strong background in devices, diagnostics, and the digital transformation of healthcare, Rebecca has a proven track record of pioneering disruptive solutions across the continuum of care. Most recently, she was VP of Corporate Development and Strategy at iRhythm Technologies (NASDAQ:IRTC), a digital healthcare provider of cardiac monitoring services. She began her career at Medtronic (NYSE:MDT), where she held progressive global leadership roles in sales and marketing. Rebecca is recognized for her ability to navigate complexity and her data-driven, customer-centric approach to creating value and delivering cutting-edge products and services to patients worldwide. She holds a BSE and MSE in Bioengineering from the University of Pennsylvania and serves on the advisory board for Diversity by Doing Healthtech.Subscribe to our newsletter to hear more about the journey from clinical trials to standard of care! Click here to subscribe! Connect with us on LinkedIn: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Rebecca Lai⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Cumby Consulting⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Rachel Medeiros⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Liz Cumby⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠About Cumby Consulting:Cumby Consulting's team of professionals deliver innovative MedTech training services for physicians, sales representatives, teaching faculty, key opinion leaders and clinical development teams. Whether you need a complete training system developed to deliver revenue sooner or a discrete training program for a specific meeting, Cumby Consulting will deliver highly strategic, efficient programs with uncompromising standards of quality.

The Harvard Plan - our collaboration with the Boston Globe, is back! In episode one, we hear what unfolded at Harvard from Donald Trump's inauguration to convocation 2025. Three main characters, inside Harvard, tell the story from their perspective: politics professor Ryan Enos, genetics professor and cancer researcher Kamila Naxerova and campus conservative Kit Parker, lieutenant colonel in the United States Army Reserve and Professor of Bioengineering and Applied Physics at Harvard. The personal perspectives of our three guides are interwoven with the dramatic timeline and unfolding news.  On the Media is supported by listeners like you. Support OTM by donating today (https://pledge.wnyc.org/support/otm). Follow our show on Instagram, Twitter and Facebook @onthemedia, and share your thoughts with us by emailing onthemedia@wnyc.org.

Clinician-scientist Jill Helms is an expert on healing. Until about age 30, people heal easily, she says, but later on, not so well. Regenerative medicine suggests avenues for improvement, she promises. Her research focuses on understanding the physical and molecular processes of healing to design better therapies. One approach awakens “sleeper” stem cells to aid healing, a new drug in trial regenerates bone, and another avenue targets infections that appear near medical devices using gum-like tissues that create sealing barriers. In many ways, nature remains our best model for healing, Helms tells host Russ Altman on this episode of Stanford Engineering's The Future of Everything podcast.Have a question for Russ? Send it our way in writing or via voice memo, and it might be featured on an upcoming episode. Please introduce yourself, let us know where you're listening from, and share your question. You can send questions to thefutureofeverything@stanford.edu.Episode Reference Links:Stanford Profile: Jill HelmsConnect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>> Twitter/X / Instagram / LinkedIn / FacebookChapters:(00:00:00) IntroductionRuss Altman introduces guest Jill Helms, a professor of surgery at Stanford University.(00:03:42) Why Study Wound HealingJill shares what led her to explore how the body repairs itself after injury.(00:04:23) How Healing WorksExplanation of physical signals, stem cells, and the stages of tissue repair.(00:07:23) Healing Declines with AgeHow healing quality and speed drop significantly after age thirty.(00:10:48) Physical vs. Biological SignalsThe biological and physical signals that work together to guide healing.(00:13:21) Regenerative MedicineTherapies designed to restore healing capacity and accelerate repair.(00:16:55) Infection and ImplantsChallenges of preventing infections around skin penetrating medical devices.(00:21:54) Nature's BlueprintUsing biological models to inspire self-renewing wound interfaces.(00:26:19)  Biomimicry and Evolutionary InsightWhat scientists are learning from animals to inform human tissue repair.(00:30:51) Future In a MinuteRapid-fire Q&A: scientific curiosity, young researchers, and supportive environments.(00:33:04) Conclusion Connect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>>Twitter/X / Instagram / LinkedIn / Facebook Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

(5:00) – A Patch for the HeartThis episode was brought to you by Mouser, our favorite place to get electronics parts for any project, whether it be a hobby at home or a prototype for work. Click HERE to learn more about advances of 3D printing in the medical space.  Become a founding reader of our newsletter: http://read.thenextbyte.com/ As always, you can find these and other interesting & impactful engineering articles on Wevolver.com.

Bioengineer Michael Fischbach studies alternative vaccine delivery methods, like self-administered creams with no needles, health professionals, or side effects. He teases a day when vaccines that don't make you feel bad come in the mail in ketchup-style packets. Such innovations would greatly improve vaccine uptake, especially in developing countries, and speed global response to novel viruses. It would change how we think about vaccines, Fischbach tells host Russ Altman on this episode of Stanford Engineering's The Future of Everything podcast.Have a question for Russ? Send it our way in writing or via voice memo, and it might be featured on an upcoming episode. Please introduce yourself, let us know where you're listening from, and share your question. You can send questions to thefutureofeverything@stanford.edu.Episode Reference Links:Stanford Profile: Michael FischbachConnect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>> Twitter/X / Instagram / LinkedIn / FacebookChapters:(00:00:00) IntroductionRuss Altman introduces guest Michael Fischbach, a professor of bioengineering at Stanford University.(00:04:24) Cream-Based VaccinesThe discovery that revealed the skin's ability to spark systemic immunity.(00:07:36) Engineering ImmunityModifying staph epidermidis to carry antigens and test immune response.(00:09:38) Tumor RegressionHow engineered bacteria triggered tumor-killing immunity in mice.(00:12:53) Antibody DiscoveryEvidence that skin exposure can generate long-lasting antibodies.(00:17:02) Antibody Response in HumansWhether humans show antibody responses to their own skin bacteria.(00:18:42) Turning Bacteria into VaccinesEmbedding harmless pathogen fragments into bacterial surface proteins.(00:20:55) Immunity Without ShotsHow mice achieved vaccine-level immunity through topical application.(00:24:00) Reimagining Vaccine DeliveryThe potential for self-applied, needle-free, and multiplexed vaccines.(00:26:50) Mechanism Behind Skin ImmunityHow skin immune cells may constantly sample microbes for defence.(00:28:14) Next Steps in DevelopmentThe path toward testing safety, dosage, and delivery in higher models.(00:29:57) Choosing Vaccine TargetsViruses and diseases that could be targets for early skin-based vaccines.(00:31:11) Safety and ReversibilityEnsuring safety with reversible bacteria and limited trial participants.(00:33:04) Transitioning to BiotechTransitioning research from Stanford to large-scale biotech development.(00:34:31) Future In a MinuteRapidfire Q&A: creative science, vaccine innovation, and biology's future.(00:36:56) Conclusion Connect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>>Twitter/X / Instagram / LinkedIn / Facebook Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

There are more human cells in your body than there are stars in the Milky Way galaxy! Cells are the fundamental building blocks of life but that doesn't mean they are simple – biology still doesn't have a full picture of how exactly a living cell works. Host Regina G. Barber talks with bioengineers Kate Adamala and Drew Endy about why scientists are trying to build a cell from scratch, piece by piece. They dive into what it would look like to be inside of a cell, why scientists are bothering with making a cell from scratch and how engineers are leading the field.Want more bioengineering stories? Email us at shortwave@npr.org.Listen to every episode of Short Wave sponsor-free and support our work at NPR by signing up for Short Wave+ at plus.npr.org/shortwave.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

In this transformative episode, Michael Jaco brings together four of the most influential voices in holistic health — Dr. Bryan Ardis, Dr. Edward Group, Dr. Henry Ealy, and Dr. Jana Schmidt — for a powerful conversation on how to heal yourself naturally and financially thrive while doing it.

Matt Dowling is the Chief Scientific Officer and Director at Medcura Team. Matt completed his graduate work at the Fischell Department of Bioengineering at the University of Maryland (UMD), after completing his undergrad in Chemical Engineering from the University of Notre Dame. At UMD, he was awarded the Fischell Fellowship in Biomedical Engineering for his innovative ideas in drug delivery systems. Matt then co-created gel-e, a novel biomaterial platform, raising several initial grants to develop the technology and to launch Medcura as a corporate entity. Matt was the recipient of the Dean's Doctoral Research Award from the UMD Clark School of Engineering for his work on chitosan-based self-assembled soft materials for use in wound treatment. He has been the Principal Investigator on $10 million in non-dilutive grant awards to Medcura; these have been used to achieve 5 FDA clearances, 2 Breakthrough Device Designations, 28 issued patents, and 10+ peer-reviewed publications in high-impact journals. Matt's work has been featured on several US and international media outlets including the BBC TV program, Brave New World with Stephen Hawking. He's also the lead vocalist in the band, Swoll.Swollhttps://www.swollmusic.com/Light the NightLLS is on a mission to cure blood cancers and improve quality of life for the nearly 1.7 million people in the U.S. living with or in remission from blood cancer.Help Team Zavadowski reach our fundraising goal! Thank you for your generous donations:https://pages.lls.org/ltn/fdk/Montcomd25/rsmith--Get in touch: robinsmithshow@gmail.comCall the hotline: +1 (301) 458-0883Follow Robin on Insight Timer: https://insighttimer.com/robinsmithBecome a supporter on Patreon: https://www.patreon.com/therobinsmithshowGot a question? We'd love to hear from you!

Digital twins and the era of personalised medicine -  Professor Merryn Tawhai, the director of the Auckland Bioengineering Institute, on reimagining healthcare with virtual doubles. 

Ed Goluch is the founder and CEO of QSM Diagnostics, makers of the Otter eQ laboratory instrument platform and FetchDx mail-in testing kits. Prior to QSM, Ed was a tenured professor in the Department of Chemical Engineering at Northeastern University. Ed earned his PhD in Bioengineering from the University of Illinois at Urbana-Champaign, and he has over 60 publications and several patents in the areas of sensors, microfluidics, and biophysics. He lives in Somerville, MA, with his wife, Liz, two Alaskan Klee Kai dogs, Odin and Gunnar, and two Balinese cats, Loki and Bandit. Topics covered in this episode:  Ed Goluch's journey into the veterinary space with QSM Diagnostics Understanding Quorum-Sensing Molecules The applications and benefits of QSM Technology for veterinarians Antibiotic stewardship Antibiogram and antibiotic resistance Streamlined mobile diagnostics FetchDx mail-in testing kits The House Call Vet Academy experience Links & Resources:  Visit the QSM Diagnostics website to learn more Find QSM Diagnostics on Instagram Find QSM Diagnostics on Facebook The House Call Vet Academy Resources:  Download Dr. Eve's FREE House Call & Mobile Vet Biz Plan Find out about the House Call Vet Academy online CE course Learn more about Dr. Eve Harrison Learn more about the Concierge Vet Mastermind Get your FREE Concierge Vet Starter Kit mini course Learn more about SoulShine Space For Vets. Use discount code SHINE15 for 15% OFF SoulShine Space For Vets! (Available for a limited time only! Rules and restrictions apply.) Learn more about 1-to-1 coaching for current & prospective house call & mobile vets Get House Call Vet swag Learn more about the House Call & Mobile Vet Virtual Conference Register TODAY for the House Call & Mobile Vet Virtual Conference, February 7th-8th, 2026!!!!!! Here's a special gift from me as a huge thank you for being a part of our wonderful House Call Vet Cafe podcast community! ☕️ GET 20% OFF your Four Sigmatic Mushroom Coffee when you order through this link! 4Sig truly is my favorite!!! Enjoy it in good health, my friends! Music:  In loving memory of Dr. Steve Weinberg.  Intro and outro guitar music was written, performed, and recorded by house call veterinarian Dr. Steve Weinberg.  Thank you to our sponsors!  Chronos  O3 Vets  This podcast is also available in video on our House Call Vet Cafe YouTube channel 

Scientific Sense ® by Gill Eapen: Prof. Dani Bassett is Professor at the University of Pennsylvania, with appointments in the Departments of Bioengineering, Electrical & Systems Engineering, Physics & Astronomy, Neurology, and Psychiatry. They are also an external professor of the Santa Fe Institute. Bassett is most well-known for blending neural and systems engineering to identify fundamental mechanisms of cognition and disease in human brain networks. Prof. Perry Zurn is Associate Professor of Philosophy at American University. He researches primarily in political philosophy, critical theory, and has collaborated in psychology and network neuroscience. He is especially interested in the politics of inquiry and voice, material histories of resistance, poetics, and ecologies. Please subscribe to this channel:https://www.youtube.com/c/ScientificSense?sub_confirmation=1

With her thought-provoking novels, Nancy Kress, acclaimed science fiction author and winner of six Nebulas, two Hugos, a Sturgeon, and the John W. Campbell Memorial Award, blends cutting-edge science with profound human questions. In this episode, we dive into her celebrated works, starting with “Beggars in Spain,” a gripping exploration of bioengineering, and “Tomorrow's Kin,” where complex scientific concepts challenge readers to expand their vocabulary and imagination. We discuss how Nancy masterfully weaves real science into her narratives, her approach to tackling humanity's response to intelligent extraterrestrial life, and the craft of writing compelling science fiction that resonates with both heart and mind. Whether you're a longtime fan or new to her work, this episode offers a fascinating look at what it takes to create authentic, thought-provoking sci-fi. https://nancykress.com/ PHOTO CREDIT: MARY GRACE LONG

Today's episode is going to focus on the management of rotator cuff retears — including tips and tricks for successful revision repair and augmentation options.We are joined today by two outstanding guests! Dr. Brian Waterman is a Professor of orthopedic surgery at Wake Forest University School of Medicine, Chief of Sports Medicine & Shoulder Surgery at Wake Forest Baptist Medical Center and Director of the Sports Medicine & Shoulder Surgery Fellowship. He is on the editorial board of the Arthroscopy Journal and American Journal of Orthopaedics. Dr. Waterman is a team physician for Wake Forest University, Winston-Salem Dash and US Ski and Snowboard.Dr. Gabriella Ode is an orthopedic surgeon specializing in sports medicine and shoulder surgery at the Hospital for Special Surgery, Assistant Professor of orthopedic surgery at Weill Cornell Medical College and adjunct faculty with the Department of Bioengineering at Clemson University. She is also a team orthopaedic surgeon for the New York Liberty of the WNBA.So, without further ado, let's get to the Exhibit Hall!

If DNA is just a string of letters, could AI learn to read it … or even write it? Bioengineering researcher Eric Nguyen reveals how AI has upended the rules of biology, potentially creating a future where disease is cured with personalized medicine, extinct species are resurrected (Jurassic Park, anyone?) and microbes designed for Mars make interplanetary life possible. Learn more about how the world's first AI-designed CRISPR model successfully edited genes — and what it means for our understanding of life itself.For a chance to give your own TED Talk, fill out the Idea Search Application: ted.com/ideasearch.Interested in learning more about upcoming TED events? Follow these links:TEDNext: ted.com/futureyouTEDSports: ted.com/sportsTEDAI Vienna: ted.com/ai-viennaTEDAI San Francisco: ted.com/ai-sf Hosted on Acast. See acast.com/privacy for more information.

Medicine stands at the threshold of a new era, where artificial intelligence and systems biology are working hand in hand to make care more personal, predictive, and precise than ever before. AI is already improving diagnostic accuracy, automating administrative tasks, and uncovering patterns in data—like retinal scans or genomics—that humans often miss. Rather than replacing doctors, AI enhances their ability to deliver more informed, precise, and efficient care. At the same time, individuals are gaining tools—from at-home diagnostics to wearable biosensors—that empower them to track and optimize their own health. This shift marks a move from reactive, disease-centered care to a proactive, data-driven model of scientific wellness. In this episode, I talk with Dr. Eric Topol, Dr. Nathan Price, Dr. Leroy Hood, Dr. Vijay Pande, and Daisy Wolf about how artificial intelligence, personalized data, and wearable technology are converging to radically transform medicine. Dr. Eric Topol is Executive Vice President of Scripps Research and founder/director of its Translational Institute, recognized as one of the top 10 most cited researchers in medicine with over 1,300 publications. A cardiologist and author of several bestselling books on the future of medicine, he leads major NIH grants in precision medicine and shares cutting-edge biomedical insights through his Ground Truths newsletter and podcast. Dr. Nathan Price is Chief Scientific Officer at Thorne HealthTech, author of The Age of Scientific Wellness, and a National Academy of Medicine Emerging Leader. He also serves on the Board on Life Sciences for the National Academies and is Affiliate Faculty in Bioengineering and Computer Science at the University of Washington. Dr. Leroy Hood is CEO and founder of Phenome Health, leading the Human Phenome Initiative to sequence and track the health of one million people over 10 years. A pioneer in systems biology and co-founder of 17 biotech companies, he is a recipient of the Lasker Prize, Kyoto Prize, and National Medal of Science. Dr. Vijay Pande is a General Partner at Andreessen Horowitz and founder of a16z Bio + Health, managing over $3 billion in life sciences and healthcare investments at the intersection of biology and AI. An Adjunct Professor at Stanford, he is known for his work in computational science, earning honors like the DeLano Prize and a Guinness World Record for Folding@Home. Daisy Wolf is an investing partner at Andreessen Horowitz, specializing in healthcare AI, consumer health, and healthcare-fintech innovation. She previously worked at Meta and in various startups, holds a JD from Yale Law, an MBA from Stanford, and a BA from Yale, and is based in New York City. This episode is brought to you by BIOptimizers. Head to bioptimizers.com/hyman and use code HYMAN10 to save 10%. Full-length episodes can be found here: Can AI Fix Our Health and Our Healthcare System? The Next Revolution In Medicine: Scientific Wellness, AI And Disease Reversal The Future of Healthcare: The Role of AI and Technology

Engineering has moved inside the body to innovate like never before. In neuro-science, brain implants can provide ‘psychic' communication for people with locked-in syndrome. In medication a new technology aims to deliver chemo therapy and other drugs directly to the parts that need them by bubbles in the blood stream. And ingestible electronics are being made to fight disease by sending antibody-directing messages straight from the gut to the brain. The BBC and the Royal Commission for the Exhibition of 1851 have come together to stage a special event. Presenter Caroline Steel is joined by Tom Oxley, professorial fellow at Melbourne Medical School; Eleanor Stride, OBE, professor of Biomaterials at the University of Oxford; Khalil Ramadi, director of the Ramadi Lab for Advanced Neuro-engineering and Translational Medicine in Abu Dhabi; Assistant Professor of Bioengineering, New York University.

Can bioengineering improve the health, vitality, and longevity of human beings? What would the future look like if the medical system were about preserving health rather than just treating symptoms? In this episode, Kevin Caldwell, the CEO, Co-Founder, and President of Ossium Health, sits down to share his thoughts… Ossium Health is a commercial-stage bioengineering company that uses its exclusive organ donor bone marrow banking platform to develop stem cell therapies for patients suffering from life-threatening hematologic conditions, organ transplant rejection, and musculoskeletal defects. Initially built from a small startup, it evolved into the clinical-stage bioengineering company it is today with one primary mission: To improve human health through bioengineering. Join the conversation now to explore:   ●      How Kevin's mindset shift in business led to the creation of Ossium. ●      Why the healthcare system isn't adequately equipped to deal with modern chronic diseases. ●      Types of cell therapies that provide relief for patients with blood and immune conditions. ●      The role that cell composition plays in the reactivity between donors and recipients.  Before founding Ossium, Kevin worked as an Engagement Manager at McKinsey's San Francisco office, where he advised clients in the biotechnology and healthcare industries. His projects spanned from conducting due diligence on biotech startup acquisitions to restructuring financially distressed biopharma companies. Over the course of his tenure, Kevin led more than 20 engagements for over a dozen clients, guiding teams in strategies for revenue growth, market-entry, and organizational restructuring. To learn about Kevin's cutting-edge work with Ossium Health, visit their website now!  

Manu Prakash is many things—biologist, engineer, inventor, philosopher—but what he isn't is conventional. Following his instincts has led Manu to his most ambitious project yet: mapping the whole tree of life, with the help of everyone on this planet. Step one: make a cheap microscope anyone can use. Foldscope co-inventor Jim Cybulski describes their invention, and their dream to supply millions of microscopes to the masses. Manu has been recognized by the Hypothesis Fund as a Scout for his bold science and enabling others to pursue their big ideas. “The Leap” is a 10-episode audio series that profiles scientists willing to take big risks to push the boundaries of discovery. It premieres on Science Friday's podcast feed every Monday until July 21. “The Leap” is a production of the Hypothesis Fund, brought to you in partnership with Science Friday.Transcript is available on sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.